Harada T, Kito S, Ishizaki F, Matsubayashi H, Katayama S, Sasaki H, Furuya H, Sakaki Y
Third Department of Internal Medicine, Hiroshima University School of Medicine, Japan.
Res Commun Chem Pathol Pharmacol. 1989 Aug;65(2):237-44.
Diagnosis of familial amyloid polyneuropathy (FAP) was investigated by recombinant DNA techniques using Southern blot hybridization in 49 constituents of FAP pedigrees originated from Nagano and Hiroshima Prefectures in Japan. The results were correlated with clinical features of the patients. Twenty-nine patients originated from Ogawa Village in Nagano Prefecture of the central part of Japan had typical clinical features of Andrade type FAP including polyneuropathy with autonomic disorders. The variant prealbumin gene with a substitution of methionine (Met) for valine (Val) at position 30 was detected in their DNA analysis (positive DNA diagnosis). In 5 cases from Nagano and Hiroshima Prefectures who had clinical features of Andrade type FAP but no family history, DNA diagnosis was positive. In another 5 members of FAP pedigrees originated from Ogawa Village without clinical features of FAP, DNA diagnosis was positive. Two cases originated from Iiyama City in Nagano, who had central nervous system disorders resembling spinocerebellar degeneration with spastic paraplegia besides clinical features of Andrade type FAP, had the Val-Met interchange variant prealbumin gene. In a case from the same Iiyama family who had only the central nervous system disorders without clinical features of FAP, DNA diagnosis was negative. These findings indicate that the presence of the variant prealbumin gene closely linked to the clinical manifestations of Andrade type FAP. The diagnostic DNA analysis was considered to be useful for the diagnosis of Andrade type FAP for sporadic cases as well as so far nonsymptomatic gene carriers. In conclusion, FAP patients originated from Iiyama City and Ogawa village were considered to have the same mutation despite the variances in clinical features.
利用重组DNA技术通过Southern印迹杂交法,对来自日本长野县和广岛县的49个家族性淀粉样多神经病(FAP)家系的成员进行了FAP诊断研究。研究结果与患者的临床特征相关。来自日本中部地区长野县小川村的29例患者具有典型的安德拉德型FAP临床特征,包括伴有自主神经功能障碍的多神经病。在他们的DNA分析中检测到30位密码子缬氨酸(Val)被蛋氨酸(Met)替代的变异型前白蛋白基因(DNA诊断阳性)。来自长野县和广岛县的5例具有安德拉德型FAP临床特征但无家族史的患者,DNA诊断为阳性。另外,来自小川村的5名无FAP临床特征的FAP家系成员,DNA诊断也为阳性。来自长野县饭山市的2例患者,除具有安德拉德型FAP临床特征外,还伴有类似脊髓小脑变性伴痉挛性截瘫的中枢神经系统疾病,他们也具有Val-Met互换变异型前白蛋白基因。来自饭山同一家族的1例仅患有中枢神经系统疾病而无FAP临床特征的患者,DNA诊断为阴性。这些发现表明,变异型前白蛋白基因的存在与安德拉德型FAP的临床表现密切相关。诊断性DNA分析被认为对散发性病例以及目前无症状的基因携带者的安德拉德型FAP诊断很有用。总之,尽管临床特征存在差异,但来自饭山市和小川村的FAP患者被认为具有相同的突变。